Client News

Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

smartbax secures additional financing to advance lead antibiotic program to IND filing

Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round

Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe

Darwin AG Announces Results of the 2026 Annual General Meeting

MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b

Finalists for the 2026 Strüngmann Award Announced: Award Recognizes Entrepreneurial Excellence and Significant Innovation Potential in Life Sciences

AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026

World Bronchiectasis Conference 2026 kicks off: driving progress for patients worldwide